Oral abstracts最新文献

筛选
英文 中文
O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors lenvatinib + pembrolizumab治疗晚期子宫内膜癌(aec)的随机3期研究:DNA错配修复缺陷(DMMR)肿瘤患者的亚组分析
Oral abstracts Pub Date : 2021-11-01 DOI: 10.1136/ijgc-2021-igcs.2
V. Makker, N. Colombo, A. Casado Herráez, A. Santin, E. Colomba, D. Miller, K. Fujiwara, S. Pignata, Sri Banerjee, B. Monk, K. Ushijima, R. Penson, R. Kristeleit, M. Fabbro, M. Orlando, H. Mackay, M. Ren, R. Orlowski, L. Dutta, D. Lorusso
{"title":"O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors","authors":"V. Makker, N. Colombo, A. Casado Herráez, A. Santin, E. Colomba, D. Miller, K. Fujiwara, S. Pignata, Sri Banerjee, B. Monk, K. Ushijima, R. Penson, R. Kristeleit, M. Fabbro, M. Orlando, H. Mackay, M. Ren, R. Orlowski, L. Dutta, D. Lorusso","doi":"10.1136/ijgc-2021-igcs.2","DOIUrl":"https://doi.org/10.1136/ijgc-2021-igcs.2","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78985034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis 尼拉帕尼维持治疗在短时间或长时间化疗后铂敏感复发卵巢癌的疗效和安全性:一项事后亚组分析
Oral abstracts Pub Date : 2021-11-01 DOI: 10.1136/ijgc-2021-igcs.17
Y. Gao, X. Wu, J. Zhu, R. Yin, J. Yang, J. Liu, J. Wang, L. Wu, Z. Liu, D. Wang, G. Lou, Hang Yang, Q. Zhou, B. Kong, Y. Huang, L. Chen, G. Li, R. An, T. Tan, J. Dong
{"title":"O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis","authors":"Y. Gao, X. Wu, J. Zhu, R. Yin, J. Yang, J. Liu, J. Wang, L. Wu, Z. Liu, D. Wang, G. Lou, Hang Yang, Q. Zhou, B. Kong, Y. Huang, L. Chen, G. Li, R. An, T. Tan, J. Dong","doi":"10.1136/ijgc-2021-igcs.17","DOIUrl":"https://doi.org/10.1136/ijgc-2021-igcs.17","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81195979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma Empower-cervical 1/GOG-3016/ENGOT-CX9:治疗复发/转移性宫颈癌的3期临床试验结果:cemiplimab vs研究者选择的化疗方案
Oral abstracts Pub Date : 2021-11-01 DOI: 10.1136/ijgc-2021-igcs.1
K. Tewari, B. Monk, I. Vergote, A. Miller, A. de Melo, H. Kim, Y. Kim, A. Lisyanskaya, V. Samouélian, D. Lorusso, F. Damian, C-L. Chang, E. Gotovkin, Shin-ichiro Takahashi, D. Ramone, J. Pikiel, J. Li, M. Mathias, M. Fury, A. Oaknin
{"title":"O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma","authors":"K. Tewari, B. Monk, I. Vergote, A. Miller, A. de Melo, H. Kim, Y. Kim, A. Lisyanskaya, V. Samouélian, D. Lorusso, F. Damian, C-L. Chang, E. Gotovkin, Shin-ichiro Takahashi, D. Ramone, J. Pikiel, J. Li, M. Mathias, M. Fury, A. Oaknin","doi":"10.1136/ijgc-2021-igcs.1","DOIUrl":"https://doi.org/10.1136/ijgc-2021-igcs.1","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76692310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
O004/#393 Does intensive follow-up improve overall survivalin endometrial cancer patients? Results from the totem randomized controlled trial 强化随访能提高子宫内膜癌患者的总生存率吗?图腾随机对照试验的结果
Oral abstracts Pub Date : 2021-11-01 DOI: 10.1136/ijgc-2021-igcs.4
P. Zola, G. Ciccone, R. Angioli, C. Terranova, E. Piovano, L. Fuso, D. di Cuonzo, E. Peirano, A. Perrone, V. Mandato, L. Zavallone, F. Chiudinelli, R. Berretta, S. Loda, S. Greggi, M. Adorni, E. Busato, G. Comerci, M. Fambrini, A. Ferrero
{"title":"O004/#393 Does intensive follow-up improve overall survivalin endometrial cancer patients? Results from the totem randomized controlled trial","authors":"P. Zola, G. Ciccone, R. Angioli, C. Terranova, E. Piovano, L. Fuso, D. di Cuonzo, E. Peirano, A. Perrone, V. Mandato, L. Zavallone, F. Chiudinelli, R. Berretta, S. Loda, S. Greggi, M. Adorni, E. Busato, G. Comerci, M. Fambrini, A. Ferrero","doi":"10.1136/ijgc-2021-igcs.4","DOIUrl":"https://doi.org/10.1136/ijgc-2021-igcs.4","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"71 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91472932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O013/#573 Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (R/MCC): phase 1B/2 engot-CX8/GOG-3024/innovaTV 205 study dose-escalation results 替妥单抗韦多汀(TV) +贝伐单抗或派姆单抗或卡铂治疗复发/转移性宫颈癌(R/MCC): 1B/2期engot-CX8/GOG-3024/innovaTV 205研究剂量递增结果
Oral abstracts Pub Date : 2021-11-01 DOI: 10.1136/ijgc-2021-igcs.13
B. Monk, T. Van Gorp, D. Lorusso, R. Eilish O’Cearbhaill, A. Westermann, Sri Banerjee, D. Collins, J. Klat, K. Madsen, J. Baurain, A. Jackson, I. Boere, S. Pignata, E. Gort, J. Moroney, I. Soumaoro, CM Andreassen, L. Nicacio, C. Gennigens, I. Vergote
{"title":"O013/#573 Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (R/MCC): phase 1B/2 engot-CX8/GOG-3024/innovaTV 205 study dose-escalation results","authors":"B. Monk, T. Van Gorp, D. Lorusso, R. Eilish O’Cearbhaill, A. Westermann, Sri Banerjee, D. Collins, J. Klat, K. Madsen, J. Baurain, A. Jackson, I. Boere, S. Pignata, E. Gort, J. Moroney, I. Soumaoro, CM Andreassen, L. Nicacio, C. Gennigens, I. Vergote","doi":"10.1136/ijgc-2021-igcs.13","DOIUrl":"https://doi.org/10.1136/ijgc-2021-igcs.13","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89542097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
12 Comparison of slow vs. rapid ajmaline infusion protocol for the diagnosis of brugada syndrome (BrS): ten year experience of the Northern Ireland inherited cardiac conditions service (NI ICC) 慢速与快速输注ajmaline方案对brugada综合征(BrS)诊断的比较:北爱尔兰遗传性心脏病服务中心(NI ICC)的十年经验
Oral abstracts Pub Date : 2021-10-01 DOI: 10.1136/heartjnl-2021-ics.12
HM Sulaiman, P. Brennan, H. Connolly, J. McOsker, T. Jardine, A. Miur
{"title":"12 Comparison of slow vs. rapid ajmaline infusion protocol for the diagnosis of brugada syndrome (BrS): ten year experience of the Northern Ireland inherited cardiac conditions service (NI ICC)","authors":"HM Sulaiman, P. Brennan, H. Connolly, J. McOsker, T. Jardine, A. Miur","doi":"10.1136/heartjnl-2021-ics.12","DOIUrl":"https://doi.org/10.1136/heartjnl-2021-ics.12","url":null,"abstract":"12 Table 1 Demographics of patients by ajmaline challenge protocol Group A: Slow protocol (1mg/kg over 10 minutes) Group B: Rapid protocol (1mg/kg over 5 minutes) p-value No of tests, n (%) 251 (61%) 163 (39%) p=0.61 (ns) Age (mean ± sd) years 40 ± 16 43 ± 15 p=0.09 (ns) Gender (male: female) 136 : 115 75 : 88 p=0.10 (ns) Indications: a) Family History of BrS b) Family history of SADS/SUD c) History of OOHCA d) ECG abnormality e) Unexplained syncope 105 78 17","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75328949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
13 Long-term safety outcomes of patients implanted with subcutaneous implantable cardioverter defibrillators 植入皮下植入式心律转复除颤器患者的长期安全性
Oral abstracts Pub Date : 2021-10-01 DOI: 10.1136/heartjnl-2021-ics.13
N. Starr, S. Esmonde, N. McKEAG, E. Chew
{"title":"13 Long-term safety outcomes of patients implanted with subcutaneous implantable cardioverter defibrillators","authors":"N. Starr, S. Esmonde, N. McKEAG, E. Chew","doi":"10.1136/heartjnl-2021-ics.13","DOIUrl":"https://doi.org/10.1136/heartjnl-2021-ics.13","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"111 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79311839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
8 Stent optimization using optical coherence tomography and its prognostic implications after percutaneous coronary intervention 光学相干断层扫描优化支架及其经皮冠状动脉介入治疗后的预后意义
Oral abstracts Pub Date : 2021-10-01 DOI: 10.1136/heartjnl-2021-ics.8
H. Rai, F. Harzer, T. Otsuka, Y. Abdelwahed, P. Antuña, F. Blachutzik, T. Koppara, L. Räber, D. Leistner, F. Alfonso, H. Nef, M. Seguchi, A. Aytekin, E. Xhepa, S. Kufner, S. Cassese, K. Laugwitz, R. Byrne, A. Kastrati, M. Joner
{"title":"8 Stent optimization using optical coherence tomography and its prognostic implications after percutaneous coronary intervention","authors":"H. Rai, F. Harzer, T. Otsuka, Y. Abdelwahed, P. Antuña, F. Blachutzik, T. Koppara, L. Räber, D. Leistner, F. Alfonso, H. Nef, M. Seguchi, A. Aytekin, E. Xhepa, S. Kufner, S. Cassese, K. Laugwitz, R. Byrne, A. Kastrati, M. Joner","doi":"10.1136/heartjnl-2021-ics.8","DOIUrl":"https://doi.org/10.1136/heartjnl-2021-ics.8","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89960562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5 Comparison of next generation P2Y12 inhibitors to clopidogrel in patients with acute coronary syndrome: an analysis from the British cardiovascular intervention society database of 382,361 ‘real-world’ patients 新一代P2Y12抑制剂与氯吡格雷在急性冠脉综合征患者中的比较:来自英国心血管干预协会数据库382361例“现实世界”患者的分析
Oral abstracts Pub Date : 2021-10-01 DOI: 10.1136/heartjnl-2021-ics.5
S. Saluja, H. Contractor, F. Mannan, Jadav Sarma, S. Garg, S. Anderson
{"title":"5 Comparison of next generation P2Y12 inhibitors to clopidogrel in patients with acute coronary syndrome: an analysis from the British cardiovascular intervention society database of 382,361 ‘real-world’ patients","authors":"S. Saluja, H. Contractor, F. Mannan, Jadav Sarma, S. Garg, S. Anderson","doi":"10.1136/heartjnl-2021-ics.5","DOIUrl":"https://doi.org/10.1136/heartjnl-2021-ics.5","url":null,"abstract":"genes DSG2, DSC2 and JUP. Conclusion Predictive testing has potentially allowed up to 789 genotype-negative individuals (and their offspring) to be reassured and discharged from long term cardiac follow-up. Our data suggests adult females are more forthcoming for predictive testing than their male counterparts. The absence of testing for several cardiomyopathy genes suggests low frequency or low penetrance of these variants in the Irish population. The large size of families in our cohort represents an opportunity to develop gene penetrance and genotype-phenotype correlation data to assist in clinical management of genotype-positive individuals.","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77566833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
21 Surgical aortic valve replacement: earlier vs newer generation bioprosthetic valves – a comparison of early hemodynamic performance 外科主动脉瓣置换术:早期与新一代生物瓣膜——早期血流动力学性能的比较
Oral abstracts Pub Date : 2021-10-01 DOI: 10.1136/heartjnl-2021-ics.21
G. Keehan, A. Vainorius, A. White, A. Soo
{"title":"21 Surgical aortic valve replacement: earlier vs newer generation bioprosthetic valves – a comparison of early hemodynamic performance","authors":"G. Keehan, A. Vainorius, A. White, A. Soo","doi":"10.1136/heartjnl-2021-ics.21","DOIUrl":"https://doi.org/10.1136/heartjnl-2021-ics.21","url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78832437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信